Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Non-Current Deffered Revenue (2016 - 2017)

Abeona Therapeutics has reported Non-Current Deffered Revenue over the past 7 years, most recently at $3.1 million for Q4 2017.

  • Quarterly results put Non-Current Deffered Revenue at $3.1 million for Q4 2017, down 16.46% from a year ago — trailing twelve months through Dec 2017 was $3.1 million (down 16.46% YoY), and the annual figure for FY2017 was $3.1 million, down 16.46%.
  • Non-Current Deffered Revenue for Q4 2017 was $3.1 million at Abeona Therapeutics, down from $3.2 million in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for ABEO hit a ceiling of $5.5 million in Q2 2013 and a floor of $2.6 million in Q1 2013.
  • Median Non-Current Deffered Revenue over the past 5 years was $4.3 million (2015), compared with a mean of $4.3 million.
  • Biggest five-year swings in Non-Current Deffered Revenue: skyrocketed 101.21% in 2014 and later dropped 16.46% in 2017.
  • Abeona Therapeutics' Non-Current Deffered Revenue stood at $5.2 million in 2013, then fell by 7.12% to $4.9 million in 2014, then fell by 12.37% to $4.3 million in 2015, then fell by 14.11% to $3.7 million in 2016, then dropped by 16.46% to $3.1 million in 2017.
  • The last three reported values for Non-Current Deffered Revenue were $3.1 million (Q4 2017), $3.2 million (Q3 2017), and $3.4 million (Q2 2017) per Business Quant data.